OPKO Health (OPK)
(Delayed Data from NSDQ)
$2.71 USD
+0.20 (7.97%)
Updated Aug 10, 2022 04:00 PM ET
3-Hold of 5 3
C Value C Growth A Momentum C VGM
Balance Sheet
Fiscal Year End for OPKO Health, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 135 | 72 | 85 | 96 | 92 |
Receivables | 260 | 286 | 135 | 144 | 166 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 87 | 132 | 53 | 42 | 49 |
Other Current Assets | 342 | 32 | 51 | 35 | 37 |
Total Current Assets | 823 | 523 | 324 | 318 | 343 |
Net Property & Equipment | 80 | 141 | 127 | 145 | 147 |
Investments & Advances | 11 | 16 | 21 | 31 | 41 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 842 | 1,156 | 1,201 | 1,315 | 1,401 |
Deposits & Other Assets | 600 | 600 | 597 | 643 | 653 |
Total Assets | 2,400 | 2,473 | 2,309 | 2,451 | 2,585 |
Liabilities & Shareholders Equity | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 276 | 101 | 63 | 47 | 74 |
Current Portion Long-Term Debt | 0 | 25 | 10 | 37 | 12 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 241 | 165 | 204 | 215 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 43 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 330 | 375 | 249 | 288 | 301 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 148 | 137 | 119 | 115 | 149 |
Convertible Debt | 188 | 222 | 211 | 57 | 29 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 15 | 37 | 88 | 199 | 220 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 715 | 802 | 695 | 660 | 699 |
Shareholders Equity | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 7 | 7 | 7 | 6 | 6 |
Capital Surplus | 3,222 | 3,153 | 3,143 | 3,004 | 2,889 |
Retained Earnings | -1,512 | -1,482 | -1,511 | -1,197 | -1,007 |
Other Equity | -31 | -4 | -22 | -20 | -1 |
Treasury Stock | 2 | 2 | 2 | 2 | 2 |
Total Shareholder's Equity | 1,685 | 1,672 | 1,615 | 1,791 | 1,885 |
Total Liabilities & Shareholder's Equity | 2,400 | 2,473 | 2,309 | 2,451 | 2,585 |
Total Common Equity | 1,685 | 1,672 | 1,615 | 1,791 | 1,885 |
Shares Outstanding | 681.34 | 670.00 | 665.60 | 586.30 | 559.40 |
Book Value Per Share | 2.47 | 2.49 | 2.43 | 3.06 | 3.37 |
Fiscal Year End for OPKO Health, Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2022 | 3/31/2022 | 12/31/2021 | 9/30/2021 | 6/30/2021 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 210 | 102 | 135 | 149 | 66 |
Receivables | 158 | 213 | 260 | 255 | 266 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 83 | 99 | 87 | 113 | 135 |
Other Current Assets | 43 | 340 | 342 | 41 | 81 |
Total Current Assets | 495 | 754 | 823 | 558 | 547 |
Net Property & Equipment | 79 | 82 | 80 | 108 | 107 |
Investments & Advances | 109 | 9 | 11 | 12 | 9 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 1,441 | 1,410 | 842 | 1,108 | 1,123 |
Deposits & Other Assets | 204 | 9 | 600 | 599 | 600 |
Total Assets | 2,370 | 2,307 | 2,400 | 2,418 | 2,422 |
Liabilities & Shareholders Equity | 6/30/2022 | 3/31/2022 | 12/31/2021 | 9/30/2021 | 6/30/2021 |
---|---|---|---|---|---|
Notes Payable | 19 | 0 | 0 | 0 | 0 |
Accounts Payable | 56 | 94 | 276 | 94 | 89 |
Current Portion Long-Term Debt | 0 | 17 | 0 | 15 | 18 |
Current Portion Capital Leases | 0 | 0 | 0 | 10 | 0 |
Accrued Expenses | 128 | 157 | 0 | 164 | 187 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 29 | 43 | 0 | 0 |
Total Current Liabilities | 215 | 309 | 330 | 283 | 304 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 177 | 125 | 148 | 134 | 136 |
Convertible Debt | 211 | 211 | 188 | 186 | 183 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 16 | 15 | 21 | 25 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 651 | 692 | 715 | 652 | 679 |
Shareholders Equity | 6/30/2022 | 3/31/2022 | 12/31/2021 | 9/30/2021 | 6/30/2021 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 8 | 7 | 7 | 7 | 7 |
Capital Surplus | 3,414 | 3,191 | 3,222 | 3,219 | 3,214 |
Retained Earnings | -1,652 | -1,550 | -1,512 | -1,438 | -1,467 |
Other Equity | -49 | -31 | -31 | -20 | -10 |
Treasury Stock | 2 | 2 | 2 | 2 | 2 |
Total Shareholder's Equity | 1,719 | 1,615 | 1,685 | 1,766 | 1,743 |
Total Liabilities & Shareholder's Equity | 2,370 | 2,307 | 2,400 | 2,418 | 2,422 |
Total Common Equity | 1,719 | 1,615 | 1,685 | 1,766 | 1,743 |
Shares Outstanding | 771.96 | 681.53 | 681.30 | 681.30 | 681.10 |
Book Value Per Share | 2.23 | 2.37 | 2.47 | 2.59 | 2.56 |